Tri Locum Partners LP

Position in ASND — Ascendis Pharma A/S

CIK 1826434 NEW YORK, NY

Position in ASND

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$58,402,088

+$1,890,290 QoQ

Shares Held

255,332

-3.7% QoQ

Ownership

0.389%

of shares outstanding

% of Portfolio

8.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Tri Locum Partners LP holds $302,334,342 across 10 Biotechnology names. ASND ranks #1 (19.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S This page	255,332	$58,402,088
2	VRTX	Vertex Pharmaceuticals Inc / Ma	129,314	$57,743,873
3	MDGL	Madrigal Pharmaceuticals, Inc.	103,288	$54,068,169
4	NUVL	Nuvalent, Inc.	308,506	$31,606,439
5	JAZZ	Jazz Pharmaceuticals plc	158,663	$29,995,240
6	ARGX	Argenx SE	31,635	$23,101,458
7	TARS	Tarsus Pharmaceuticals, Inc.	252,588	$17,719,048
8	DNTH	Dianthus Therapeutics, Inc. /DE/	145,543	$12,213,968

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$58,402,088	255,332	-3.7%	Shares	Sole	2026-05-18
2025-12-31	$56,511,798	265,015	+51.6%	Shares	Sole	2026-02-17
2025-09-30	$34,757,753	174,829	+18.4%	Shares	Sole	2025-11-14
2025-06-30	$25,483,009	147,642	+356.7%	Shares	Sole	2025-08-14
2025-03-31	$5,038,174	32,325	-85.8%	Shares	Sole	2025-05-14
2024-06-30	$31,062,181	227,762	+102.1%	Shares	Sole	2024-08-14
2024-03-31	$17,032,323	112,670	+13.2%	Shares	Sole	2024-05-15
2023-12-31	$12,538,322	99,550	+0.3%	Shares	Sole	2024-02-14
2022-12-31	$12,117,127	99,215	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.